Gaur Diagno launches ' Worlds only Pan Cancer marker test' in India
Gaur Diagno, a diagnostic company based in India with a strong presence of over 20 years in pharmaceutical industry launches worlds only Pan cancer marker. The test has been designed by AMDL Inc, a US based bio-pharmaceutical company and its brand name is Onko-sure.
-- Gaur Diagno, a diagnostic company based in India with a strong presence of over 20 years in pharmaceutical industry launches worlds only Pan cancer marker. The test has been designed by AMDL Inc, a US based bio-pharmaceutical company and its brand name is Onko-sure.
Onko-sure is the only test in the world which can detect all kind of cancer. With a single blood draw, the presence, if any, of any of the 13 different types of cancer can be detected in the body i.e. lung, breast, stomach, liver, colon, rectal, ovarian, esophageal, cervical, trophoblastic, thyroid, malignant, lymphoma, pancreatic.
Onko-sure measures the amount of FDP (fibrin degradation products) in the patient's serum. The production of FDP is restricted in healthy individuals, but it is overproduced by enzymes released by cancer cells, and as a by-product of cancer related processes. It has been reported that FDP levels are increased in the body above the normal level, even during the early stages of cancer, when the symptoms usually are not visible; therefore, this test can even be done on those people with a family history of cancer, or those who are alcohol or tobacco consumers.
It is also the only IVD test for lung cancer and quickly detects a reoccurrence of cancer after treatment and during remission, thus a useful tool for monitoring of cancer.
Onko-sure is the only approved FDP test for cancer detection and is a result of about more than 40 years of AMDL Inc research and its effectiveness has been determined by clinical trials conducted in many parts of the world like USA, Canada, S.KOREA, Taiwan & Europe, where it is being used successfully in.
Mr. Raman Poonchhi, Director, Gaur Diagno comments "around ten lakh cancer patients are added every year. Most of the cancers are treatable provided they are detected at an early stage so that treatment could be started promptly. Thus Onko-sure can save lives by universally detecting early signs of cancer. This is possible by making people aware and thus Gaur Diagno is planning to spend 25% on its revenue in Awareness programmes and other social services like building hospitals that would provide free treatment to poor and needy patients."
The joint effort of Gaur Diagno and AMDL is a step ahead to support the global commercialization of the test in India. Gaur Diagno is responsible of carrying on an effective marketing strategy and its implementation to drive market adoption and bring consumer awareness.
Notes to Editor
About Gaur Diagno:
Gaur Diagno, a diagnostic company is based in India with a strong presence of over 20 years in the pharmaceutical Industry. The company is committed to market quality medicines and tests at affordable prices to address medical needs most sought after. Gaur Diagno is driven by its mission to increase the momentum of its business in Diagnostics in the developed and emerging markets.